Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Amortization - IntangiblesConsolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Sotera Health (SHC) EBIT (2020 - 2025)

Sotera Health (SHC) has 6 years of EBIT data on record, last reported at $108.4 million in Q4 2025.

  • For Q4 2025, EBIT rose 24.4% year-over-year to $108.4 million; the TTM value through Dec 2025 reached $392.8 million, up 31.97%, while the annual FY2025 figure was $392.8 million, 31.97% up from the prior year.
  • EBIT reached $108.4 million in Q4 2025 per SHC's latest filing, down from $114.3 million in the prior quarter.
  • Across five years, EBIT topped out at $114.3 million in Q3 2025 and bottomed at $33.4 million in Q1 2023.
  • Average EBIT over 5 years is $73.6 million, with a median of $71.9 million recorded in 2022.
  • The widest YoY moves for EBIT: up 72.89% in 2023, down 37.62% in 2023.
  • A 5-year view of EBIT shows it stood at $66.4 million in 2021, then dropped by 9.42% to $60.2 million in 2022, then skyrocketed by 72.89% to $104.0 million in 2023, then dropped by 16.23% to $87.1 million in 2024, then rose by 24.4% to $108.4 million in 2025.
  • Per Business Quant database, its latest 3 readings for EBIT were $108.4 million in Q4 2025, $114.3 million in Q3 2025, and $97.7 million in Q2 2025.